FDA and CDC investigate Salmonella outbreak linked to “Live it Up” Super Greens supplement powder

Investigation focuses on a greens powder sold online

The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention are investigating a multistate outbreak of Salmonella Typhimurium infections linked to “Live it Up” brand Super Greens dietary supplement powder. Health officials say the product is primarily sold online, including through the company website and major marketplaces, and they are urging consumers and retailers to stop using and selling affected items.

According to the FDA’s outbreak investigation page, officials reported 45 illnesses across 21 states, including 12 hospitalizations and no deaths at the time of the latest update. Reported illness onset dates ranged from August 22, 2025 through December 30, 2025, with investigators noting that more recent illnesses may not yet be captured in official counts because outbreak case confirmation often takes weeks.

What products are affected and what consumers should do

The FDA’s advisory identified “Live it Up” Super Greens supplement powder in original and wild berry flavors with expiration dates from 08/2026 to 01/2028 as the focus of the investigation. The agency recommended that consumers and retailers should not eat, sell, or serve the product and should throw it away or return it to where it was purchased.

Officials also emphasized sanitation. Because powders can spread contamination to kitchen counters, scoops, containers and other contact surfaces, the FDA advised people who handled the product to carefully clean and sanitize any surfaces or containers that may have been exposed, using safe handling and cleaning guidance to reduce cross-contamination risk.

Symptoms, risk groups, and recall steps

Salmonella infection commonly causes diarrhea, fever and abdominal cramps, typically starting 12 to 72 hours after exposure and lasting four to seven days. The FDA noted that young children, older adults and people with weakened immune systems are more likely to experience severe illness, and it recommends contacting a healthcare provider if symptoms develop after consuming the product.

The FDA said it recommended a recall, and the firm agreed to initiate a voluntary recall as of January 14, 2026. Investigators are continuing traceback and sampling work to identify the contamination source and to determine whether additional products may be affected as the investigation evolves.